Home > Insider Trading > Filing (0001213900-20-006779)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1686223	Khoso Baluch	C/O Cormedix Inc. 400 Connell Drive, Suite 5000 Berkeley Heights NJ 07922	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-03-18	3,500	$2.61	56,075	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy Common Stock)	$5.63	2030-02-25	100,630	100,630	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$6.82	2029-09-26	120,000	120,000	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$8.30	2029-01-10	69,600	69,600	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$12.60	2026-09-30	250,000	250,000	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$12.60	2026-09-30	60,000	60,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2030-02-25	100,630	100,630	Direct
2029-09-26	120,000	120,000	Direct
2029-01-10	69,600	69,600	Direct
2026-09-30	250,000	250,000	Direct
2026-09-30	60,000	60,000	Direct

Footnotes

These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
The options will vest over four (4) years in four (4) equal annual installments on the first four (4) anniversaries of September 26, 2019, provided, in all cases, that Executive remains an employee of, or a consultant to, the Company through the applicable vesting date.
These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. These options include options to purchase 7,000 shares that are subject to vesting each on January 10, 2021 and January 10, 2022.
These options were granted 9/30/2016. The option vests as follows: 25% on 10/3/2017, 25% on 10/3/2018, 25% on 10/3/2019, and 25% on 10/3/2020.
These options were granted 9/30/2016. The option vests based on certain performance milestones. If such milestones are met prior to 12/31/18, then the option will not vest until 12/31/18. The option will be forfeited if such milestones are not met by 10/3/2020.